387 related articles for article (PubMed ID: 31105019)
21. Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
Huynh MT; Nguyen TT; Grison S; Lascols O; Fernandez E; Barbu V
Rev Esp Enferm Dig; 2019 Oct; 111(10):775-788. PubMed ID: 31538484
[TBL] [Abstract][Full Text] [Related]
22. Progressive familial intrahepatic cholestasis: a personal perspective.
Knisely AS
Pediatr Dev Pathol; 2000; 3(2):113-25. PubMed ID: 10679031
[TBL] [Abstract][Full Text] [Related]
23. Molecular basis of intrahepatic cholestasis.
Carlton VE; Pawlikowska L; Bull LN
Ann Med; 2004; 36(8):606-17. PubMed ID: 15768832
[TBL] [Abstract][Full Text] [Related]
24. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
Colombo C; Okolicsanyi L; Strazzabosco M
Dig Liver Dis; 2000 Mar; 32(2):152-9. PubMed ID: 10975791
[TBL] [Abstract][Full Text] [Related]
25. Genetic cholestasis, causes and consequences for hepatobiliary transport.
Jansen PL; Sturm E
Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
[TBL] [Abstract][Full Text] [Related]
26. Panel-Based Next-Generation Sequencing for the Diagnosis of Cholestatic Genetic Liver Diseases: Clinical Utility and Challenges.
Chen HL; Li HY; Wu JF; Wu SH; Chen HL; Yang YH; Hsu YH; Liou BY; Chang MH; Ni YH
J Pediatr; 2019 Feb; 205():153-159.e6. PubMed ID: 30366773
[TBL] [Abstract][Full Text] [Related]
27. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
[TBL] [Abstract][Full Text] [Related]
28. Hepatic cytochrome P450 deficiency in mouse models for intrahepatic cholestasis predispose to bile salt-induced cholestasis.
Kunne C; de Graaff M; Duijst S; de Waart DR; Oude Elferink RP; Paulusma CC
Lab Invest; 2014 Oct; 94(10):1103-13. PubMed ID: 25068656
[TBL] [Abstract][Full Text] [Related]
29. Progressive familial intrahepatic cholestasis. Genetic basis and treatment.
Jacquemin E
Clin Liver Dis; 2000 Nov; 4(4):753-63. PubMed ID: 11232355
[TBL] [Abstract][Full Text] [Related]
30. Reduced hepatic expression of farnesoid X receptor in hereditary cholestasis associated to mutation in ATP8B1.
Alvarez L; Jara P; Sánchez-Sabaté E; Hierro L; Larrauri J; Díaz MC; Camarena C; De la Vega A; Frauca E; López-Collazo E; Lapunzina P
Hum Mol Genet; 2004 Oct; 13(20):2451-60. PubMed ID: 15317749
[TBL] [Abstract][Full Text] [Related]
31. Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing.
Vitale G; Pirillo M; Mantovani V; Marasco E; Aquilano A; Gamal N; Francalanci P; Conti F; Andreone P
Ann Hepatol; 2016; 15(5):795-800. PubMed ID: 27493120
[TBL] [Abstract][Full Text] [Related]
32. Overview of Progressive Familial Intrahepatic Cholestasis.
Hassan S; Hertel P
Clin Liver Dis; 2022 Aug; 26(3):371-390. PubMed ID: 35868680
[TBL] [Abstract][Full Text] [Related]
33. Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications.
Yeap SP; Harley H; Thompson R; Williamson KD; Bate J; Sethna F; Farrell G; Hague WB
J Gastroenterol Hepatol; 2019 Feb; 34(2):425-435. PubMed ID: 29992621
[TBL] [Abstract][Full Text] [Related]
34. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
[TBL] [Abstract][Full Text] [Related]
35. Xenobiotic Nuclear Receptor Signaling Determines Molecular Pathogenesis of Progressive Familial Intrahepatic Cholestasis.
Kim KH; Choi JM; Li F; Arizpe A; Wooton-Kee CR; Anakk S; Jung SY; Finegold MJ; Moore DD
Endocrinology; 2018 Jun; 159(6):2435-2446. PubMed ID: 29718219
[TBL] [Abstract][Full Text] [Related]
36. A female of progressive familial intrahepatic cholestasis type 3 caused by heterozygous mutations of ABCB4 gene and her cirrhosis improved after treatment of ursodeoxycholic acid: a case report.
Qiao F; Ren F; Lu W; Yang H; Mo G; Wang S; Liu L; Xu X
BMC Med Genomics; 2023 Jul; 16(1):171. PubMed ID: 37488596
[TBL] [Abstract][Full Text] [Related]
37. DHPLC screening for mutations in progressive familial intrahepatic cholestasis patients.
Shapiro R; Anikster Y; Yardeni T; Korem S; Hartman K; Shamir R; Broide E; Levine A; Bujanover Y; Bercovich D
J Hum Genet; 2010 May; 55(5):308-13. PubMed ID: 20414253
[TBL] [Abstract][Full Text] [Related]
38. An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy.
Dixon PH; Sambrotta M; Chambers J; Taylor-Harris P; Syngelaki A; Nicolaides K; Knisely AS; Thompson RJ; Williamson C
Sci Rep; 2017 Sep; 7(1):11823. PubMed ID: 28924228
[TBL] [Abstract][Full Text] [Related]
39. Hepatic immunohistochemistry of bile transporters in progressive familial intrahepatic cholestasis.
El-Guindi MA; Sira MM; Hussein MH; Ehsan NA; Elsheikh NM
Ann Hepatol; 2016; 15(2):222-9. PubMed ID: 26845599
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a Novel Missense Mutation in
Saleem K; Cui Q; Zaib T; Zhu S; Qin Q; Wang Y; Dam J; Ji W; Liu P; Jia X; Wu J; Bai J; Fu S; Sun W
Dis Markers; 2020; 2020():6292818. PubMed ID: 32626542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]